My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 125

    1.

    Melatonin in Alzheimer's disease and other neurodegenerative disorders.

    Srinivasan V, Pandi-Perumal SR, Cardinali DP, Poeggeler B, Hardeland R.

    Behav Brain Funct. 2006 May 4;2:15.PMID: 16674804 [PubMed]Related articlesFree article

    2.

    Beneficial effects of melatonin in experimental models of Alzheimer disease.

    Cheng Y, Feng Z, Zhang QZ, Zhang JT.

    Acta Pharmacol Sin. 2006 Feb;27(2):129-39. Review.PMID: 16412260 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Melatonin oxidative stress and neurodegenerative diseases.

    Srinivasan V.

    Indian J Exp Biol. 2002 Jun;40(6):668-79. Review.PMID: 12587715 [PubMed - indexed for MEDLINE]Related articles

    4.

    Antioxidants and neuroprotection in the adult and developing central nervous system.

    Kaur C, Ling EA.

    Curr Med Chem. 2008;15(29):3068-80. Review.PMID: 19075654 [PubMed - indexed for MEDLINE]Related articles

    5.

    Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease.

    Albers DS, Beal MF.

    J Neural Transm Suppl. 2000;59:133-54. Review.PMID: 10961426 [PubMed - indexed for MEDLINE]Related articles

    6.

    Role of oxidative stress and antioxidants in neurodegenerative diseases.

    Rao AV, Balachandran B.

    Nutr Neurosci. 2002 Oct;5(5):291-309. Review.PMID: 12385592 [PubMed - indexed for MEDLINE]Related articles

    7.

    Amyloid, cholinesterase, melatonin, and metals and their roles in aging and neurodegenerative diseases.

    Lahiri DK, Chen DM, Lahiri P, Bondy S, Greig NH.

    Ann N Y Acad Sci. 2005 Nov;1056:430-49. Review.PMID: 16387707 [PubMed - indexed for MEDLINE]Related articles

    8.

    Melatonin and Parkinson's disease.

    Mayo JC, Sainz RM, Tan DX, Antolín I, Rodríguez C, Reiter RJ.

    Endocrine. 2005 Jul;27(2):169-78. Review.PMID: 16217130 [PubMed - indexed for MEDLINE]Related articles

    9.

    Melatonin and mitochondrial function.

    Leon J, Acuña-Castroviejo D, Sainz RM, Mayo JC, Tan DX, Reiter RJ.

    Life Sci. 2004 Jul 2;75(7):765-90. Review.PMID: 15183071 [PubMed - indexed for MEDLINE]Related articles

    10.

    Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases.

    Monnet-Tschudi F, Zurich MG, Boschat C, Corbaz A, Honegger P.

    Rev Environ Health. 2006 Apr-Jun;21(2):105-17. Review.PMID: 16898674 [PubMed - indexed for MEDLINE]Related articles

    11.

    Recent developments of melatonin related antioxidant compounds.

    Suzen S.

    Comb Chem High Throughput Screen. 2006 Jul;9(6):409-19. Review.PMID: 16842222 [PubMed - indexed for MEDLINE]Related articles

    12.

    The role of melatonin in the neurodegenerative diseases.

    Olakowska E, Marcol W, Kotulska K, Lewin-Kowalik J.

    Bratisl Lek Listy. 2005;106(4-5):171-4. Review.PMID: 16080363 [PubMed - indexed for MEDLINE]Related articles

    13.

    A neuronal model of Alzheimer's disease: an insight into the mechanisms of oxidative stress-mediated mitochondrial injury.

    Sompol P, Ittarat W, Tangpong J, Chen Y, Doubinskaia I, Batinic-Haberle I, Abdul HM, Butterfield DA, St Clair DK.

    Neuroscience. 2008 Apr 22;153(1):120-30. Epub 2008 Feb 7.PMID: 18353561 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.

    Reddy PH, Beal MF.

    Trends Mol Med. 2008 Feb;14(2):45-53. Epub 2008 Jan 22.PMID: 18218341 [PubMed - indexed for MEDLINE]Related articles

    15.

    Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and parkinsonism.

    Reiter RJ, Cabrera J, Sainz RM, Mayo JC, Manchester LC, Tan DX.

    Ann N Y Acad Sci. 1999;890:471-85. Review.PMID: 10668453 [PubMed - indexed for MEDLINE]Related articles

    17.

    Differential effects of melatonin on amyloid-beta peptide 25-35-induced mitochondrial dysfunction in hippocampal neurons at different stages of culture.

    Dong W, Huang F, Fan W, Cheng S, Chen Y, Zhang W, Shi H, He H.

    J Pineal Res. 2009 Dec 23. [Epub ahead of print]PMID: 20041986 [PubMed - as supplied by publisher]Related articles

    18.

    Clinical perspectives for the use of melatonin as a chronobiotic and cytoprotective agent.

    Cardinali DP, Furio AM, Reyes MP.

    Ann N Y Acad Sci. 2005 Dec;1057:327-36.PMID: 16399904 [PubMed - indexed for MEDLINE]Related articles

    19.

    The use of melatonin in Alzheimer's disease.

    Cardinali DP, Brusco LI, Liberczuk C, Furio AM.

    Neuro Endocrinol Lett. 2002 Apr;23 Suppl 1:20-3. Review.PMID: 12019347 [PubMed - indexed for MEDLINE]Related articles

    20.

    Melatonin prevents amyloid protofibrillar induced oxidative imbalance and biogenic amine catabolism.

    Gunasingh MJ, Philip JE, Ashok BS, Kirubagaran R, Jebaraj WC, Davis GD, Vignesh S, Dhandayuthapani S, Jayakumar R.

    Life Sci. 2008 Jul 18;83(3-4):96-102. Epub 2008 May 27.PMID: 18590917 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk